Patient Care: Drugs, Devices & Services

Own the businesses that deliver patient care across medicines, medical devices, diagnostics and health services, rather than concentrate on a single drug platform. Lilly's recent company-specific coverage keeps commercial treatment demand in focus, while device and service providers diversify the sources of earnings. This is a diversified healthcare basket, not a claim that every holding benefits from obesity treatments; reimbursement pressure and clinical execution remain key risks. Catalysts: - 2026-10-20 LLY: Eli Lilly shares climb 3.6% as its treatment franchise remains in focus (https://www.marketbeat.com/instant-alerts/price-eli-lilly-and-company-nyse-lly-shares-climb-36-still-a-buy-2026-10-20/) Launch basket (equal weight): LLY, MDT, JNJ, TMO, UNH, ABT, GEHC, BSX Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.